Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|July 8, 2009
The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profilesMichael C J Quinn, Daniel J Wilson, Fiona Young, et al.
Plos One|October 3, 2012
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcomePaulina M Wojnarowicz, Kathleen Klein Oros, Michael C J Quinn, et al.
BMC Cancer|August 31, 2012
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancerIsabelle J Létourneau, Michael C J Quinn, Lu-Lin Wang, et al.
European Journal of Human Genetics : EJHG|May 25, 2024
Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics servicesStephanie Best, Zoe Fehlberg, Christopher Richards, et al.
Molecular Oncology|February 19, 2013
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancerKaren Gambaro, Michael C J Quinn, Paulina M Wojnarowicz, et al.
Plos One|May 14, 2015
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using GefitinibDarrell C Bessette, Erik Tilch, Tatjana Seidens, et al.
Journal of Molecular and Cellular Cardiology|January 6, 2026
Atrial t-tubules adopt a distinct developmental state as Ca2+ handling matures postnatallyC E R Smith, C J Quinn, J D Clarke, et al.
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Thrombosis Research|April 29, 2019
Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemiaM K Mateos, T N Trahair, C Mayoh, et al.
Gynecologic Oncology|September 23, 2017
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyKathleen N Moore, David Tritchler, Kenneth M Kaufman, et al.
Pageof 5